Covaxin’s Safety Profile Under Scrutiny: Bharat Biotech Responds to Study Citing Risks
Bharat Biotech, the pioneering developer of India’s first indigenous COVID-19 vaccine Covaxin, has staunchly defended its product’s safety profile amidst recent study findings suggesting potential risks. In response to reports citing an